Why Buy Domino’s Pizza Stock?
When you think of growth stocks, you probably imagine technology…
Sell
30
SKHCF Quote, Financials, Valuation and Earnings
Last price:
$15.86
Seasonality move
:
-0.66%
Day range:
$15.86 - $15.86
52-week range:
$15.25 - $21.89
Dividend yield:
4.43%
P/E ratio:
22.75x
P/S ratio:
1.29x
P/B ratio:
1.44x
Volume:
--
Avg. volume:
3.1K
1-year change:
-27.39%
Market cap:
$7.6B
Revenue:
$5.9B
EPS (TTM):
$0.70
Analysts' Opinion
-
Consensus RatingSonic Healthcare has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Sonic Healthcare has an estimated downside of -- from its current price of $15.86.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $15.86.
Fair Value
-
According to the consensus of 0 analysts, Sonic Healthcare has -- downside to fair value with a price target of -- per share.
SKHCF vs. S&P 500
-
Over the past 5 trading days, Sonic Healthcare has underperformed the S&P 500 by -11.07% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Sonic Healthcare does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Sonic Healthcare revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Sonic Healthcare reported revenues of --.
Earnings Growth
-
Sonic Healthcare earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Sonic Healthcare reported earnings per share of --.
Enterprise value:
9.3B
EV / Invested capital:
--
Price / LTM sales:
1.29x
EV / EBIT:
16.06x
EV / Revenue:
1.59x
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
8.54x
Gross Profit (TTM):
$4.9B
Return On Assets:
3.61%
Net Income Margin (TTM):
5.73%
Return On Equity:
6.28%
Return On Invested Capital:
4.6%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2016-06-30 | 2017-06-30 | 2018-06-30 | 2017-06-30 | 2018-06-30 | |
| Income Statement | ||||||
| Revenue | $3.6B | $3.8B | $4.2B | -- | -- | |
| Gross Profit | $3B | $3.2B | $3.5B | -- | -- | |
| Operating Income | $409.5M | $431.7M | $480.5M | -- | -- | |
| EBITDA | $648.8M | $653.8M | $724.9M | -- | -- | |
| Diluted EPS | $0.80 | $0.77 | $0.86 | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.7B | $1.7B | $1.6B | $1.4B | $1.6B | |
| Total Assets | $8.3B | $8.8B | $8.6B | $8.6B | $9.9B | |
| Current Liabilities | $1.4B | $1.7B | $1.4B | $1.2B | $1.6B | |
| Total Liabilities | $4.4B | $3.9B | $3.5B | $3.4B | $4.5B | |
| Total Equity | $3.9B | $4.9B | $5.1B | $5.2B | $5.4B | |
| Total Debt | $2.2B | $1.4B | $1.1B | $1.1B | $2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2011-12-31 | 2012-12-31 | 2013-12-31 | 2012-12-31 | 2013-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $230.6M | $212.5M | |
| Cash From Investing | -$469M | -$209.1M | -$354M | -$106M | -$189.8M | |
| Cash From Financing | -$119.7M | -$224.9M | -$97.7M | -$111.4M | -$29.1M | |
| Free Cash Flow | -- | -- | -- | $132.5M | $113.1M | |
SKHCF
Sector
Market Cap
$7.6B
$49.2M
Price % of 52-Week High
72.45%
48.57%
Dividend Yield
4.43%
0%
Shareholder Yield
2.51%
-0.74%
1-Year Price Total Return
-27.39%
-30.94%
Beta (5-Year)
1.133
0.754
Dividend yield:
4.43%
Annualized payout:
$0.67
Payout ratio:
109.25%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$16.57
200-day SMA
Sell
Level
$17.64
Bollinger Bands (100)
Sell
Level
16.9 - 18.7
Chaikin Money Flow
Sell
Level
-214.4K
20-day SMA
Sell
Level
$16.93
Relative Strength Index (RSI14)
Sell
Level
42.79
ADX Line
Sell
Level
19.78
Williams %R
Neutral
Level
-79.1096
50-day SMA
Sell
Level
$17.34
MACD (12, 26)
Sell
Level
-0.37
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
596.1K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.2834)
Buy
CA Score
(Annual)
Level (0.3496)
--
Beneish M-Score
(Annual)
Level (--)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-0.5478)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the U.K., the second largest in Belgium and New Zealand and the third largest in the U.S. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second largest player in diagnostic imaging in Australia and the largest operator of medical centres in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the U.S. and 35% in Europe.
Stock Forecast FAQ
In the current month, SKHCF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SKHCF average analyst price target in the past 3 months is --.
-
Where Will Sonic Healthcare Stock Be In 1 Year?
According to analysts, the consensus estimate is that Sonic Healthcare share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Sonic Healthcare?
Analysts are divided on their view about Sonic Healthcare share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sonic Healthcare is a Sell and believe this share price will rise from its current level to --.
-
What Is Sonic Healthcare's Price Target?
The price target for Sonic Healthcare over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SKHCF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Sonic Healthcare is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of SKHCF?
You can purchase shares of Sonic Healthcare via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sonic Healthcare shares.
-
What Is The Sonic Healthcare Share Price Today?
Sonic Healthcare was last trading at $15.86 per share. This represents the most recent stock quote for Sonic Healthcare. Yesterday, Sonic Healthcare closed at $15.86 per share.
-
How To Buy Sonic Healthcare Stock Online?
In order to purchase Sonic Healthcare stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Companies Are In The VanEck Semiconductor ETF?
There’s a lot to love about the VanEck Semiconductor ETF,…
How High Can Palantir Stock Go?
Palantir Technologies (NASDAQ:PLTR) has been one of the undisputed victors…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 121x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Sell
39
DOGZ alert for Jan 4
Dogness (International) [DOGZ] is down 20.52% over the past day.
Buy
66
DMRC alert for Jan 4
Digimarc [DMRC] is up 16.19% over the past day.
Sell
39
MSTR alert for Jan 4
MicroStrategy [MSTR] is up 13.33% over the past day.
